Attenua
ClosedUnited States · Founded 2015 · $35.0M raised
- Founded
- 2015
- Business Model
- B2B
- Website
- attenua.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AApr 2018
- Rounds
- 1
About
Attenua is a clinical-stage biopharmaceutical company developing novel medicines to treat chronic cough and debilitating conditions neglected by Big Pharma.
Summary
Attenua is a Biotech company based in United States, founded in 2015. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Apr 2018. Investors include Omega Funds, OrbiMed and Redmile Group.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2018
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...